//=time() ?>
Excited about the potential of cfDNA genomics & methylation to understand prostate cancer resistance and identify NEPC. Our new study @jclinicalinvest with @FrancescaBZNY and many great collaborators @aromanel @DrScottTagawa and many more @PCF_Science https://t.co/EoP3L5P9BM